STOCK TITAN

US Antimony director buys 1,400 more shares

UNITED STATES ANTIMONY CORP (UAMY) director Blaise A. Aguirre reported a purchase of 1,400 shares of Common Stock on 2026-08-31 in an open-market or private transaction at $5.035 per share.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

UNITED STATES ANTIMONY CORP (UAMY) director Blaise A. Aguirre reported a purchase of 1,400 shares of Common Stock on 2026-08-31 in an open-market or private transaction at $5.035 per share. Following this transaction, Aguirre directly holds 878,092 shares of UAMY common stock.

Positive

  • None.

Negative

  • None.
Insider Aguirre Blaise A.
Role Director
Bought 1,400 shs ($7K)
Type Security Shares Price Value
Purchase Common Stock 1,400 $5.035 $7K
Holdings After Transaction: Common Stock — 878,092 shares (Direct)
Shares purchased 1,400 shares of Common Stock Open-market or private transaction on 2026-08-31
Purchase price per share $5.035 per share Price reported for the 1,400-share transaction
Shares owned after transaction 878,092 shares of Common Stock Direct ownership position following the reported purchase

FAQ

What insider transaction did UAMY director Blaise A. Aguirre report?

Blaise A. Aguirre reported purchasing 1,400 shares of UNITED STATES ANTIMONY CORP (UAMY) Common Stock on 2026-08-31 in an open-market or private transaction at $5.035 per share.

How many UAMY shares does Blaise A. Aguirre own after this Form 4 transaction?

After the reported purchase, Blaise A. Aguirre directly owns 878,092 shares of UNITED STATES ANTIMONY CORP (UAMY) Common Stock, according to the Form 4 filing.

What was the price paid per share in Blaise A. Aguirre’s UAMY stock purchase?

The reported purchase price was $5.035 per share for UNITED STATES ANTIMONY CORP (UAMY) Common Stock in the 1,400-share transaction on 2026-08-31.

Was Blaise A. Aguirre’s UAMY trade made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not checked, so the reported UAMY trade was not affirmed as being made under a Rule 10b5-1 trading plan.

Is Blaise A. Aguirre’s ownership in UAMY reported as direct or indirect?

The Form 4 reports Blaise A. Aguirre’s 878,092 shares of UNITED STATES ANTIMONY CORP (UAMY) Common Stock as held with direct ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Aguirre Blaise A.

(Last)(First)(Middle)
4438 W. LOVERS LANE, UNIT 100

(Street)
DALLAS TEXAS 75209

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
UNITED STATES ANTIMONY CORP [ UAMY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/31/2026P1,400A$5.035878,092D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Blaise Aguirre08/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)